National Cancer Institute
Found 143 results for your search:
Total relevant funding to Gene Therapy for this search:
$35,689,813
Fiscal Year FY 2017
Research Topic [Gene Therapy]
Modify this Search New Search
Close

Modify Search Criteria

Some search criteria may be modified to refine your current search.

Select criteria to modify:

Add or remove search options:

Select criteria above to see additional search options

Cancel
Showing 1 - 50 of 143 results
Clipboard
Project Title Sorted ascending Project Number Funded Amount
Relevant Funding
Principal
Investigator
Institution
1
A Genetic Toolbox for the Identification and Interrogation of Tumor Cells of Origin, Propagation, and Recurrence From Patient-derived Oncogenic Drivers 5R33CA202900-02 $412,553 $412,553 BREUNIG, JOSHUA CEDARS-SINAI MEDICAL CENTER
2
A microRNA mediating vascular directed fibrinolysis and tumor progression 1F31CA213793-01 $0 MCCANN, JAMES UNIV OF NORTH CAROLINA CHAPEL HILL
3
A microRNA mediating vascular directed fibrinolysis and tumor progression 7F31CA213793-02 $33,314 $33,314 MCCANN, JAMES UNIVERSITY OF VIRGINIA
4
A Nanotechnology Platform for Suicide Gene Therapy of Recurring Ovarian Cancer 5R01CA175318-03 $354,563 $354,563 HATEFI, ARASH RUTGERS, THE STATE UNIV OF N.J.
5
A New Ovarian Cancer Mouse Model Based on Nanoparticle Gene Delivery 1R03CA216127-01 $77,000 $77,000 YANG, YANG YALE UNIVERSITY
6
A novel miR-198 replacement therapy for pancreatic cancer 5R01CA183984-03 $473,915 $236,958 YAO, QIZHI BAYLOR COLLEGE OF MEDICINE
7
A Phase 1 Study of M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma. 1R01CA217179-01 $566,814 $566,814 MARKERT, JAMES UNIVERSITY OF ALABAMA AT BIRMINGHAM
8
A Phase I Study of Intracranially Administered Carboxylesterase-Expressing Neural Stem Cells in Combination with Intravenous Irinotecan in Patients with Recurrent High Grade Gliomas 5R01CA198076-03 $1 $1 PORTNOW, JANA BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
9
Adenoviral delivery of protein-based therapeutics to the tumor microenvironment 5F32CA189372-03 $48,216 $48,216 SMITH, SHEENA UNIVERSITY OF ZURICH
10
Adoptive Cell Transfer Immunotherapy of Cancer ZIA BC 010984 $1,629,581 $651,832 Rosenberg, Steven CCR (NCI)
11
Adoptive T cell Therapy for Pediatric Leukemia ZIA BC 011565 $776,399 $232,920 Fry, Terry CCR (NCI)
12
Allogeneic T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor ZIA BC 011415 $13,582 $13,582 Kochenderfer, James CCR (NCI)
13
AVGN7, a Novel Gene Therapeutic for Treating Cancer Cachexia 1R44CA221539-01 $1,206,955 $1,206,955 RODGERS, BUEL AAVOGEN, INC.
14
Biology and Transplantation of the Hematopoietic Stem Cell 5P01CA065493-23 $1,914,865 $421,270 WAGNER, JOHN UNIVERSITY OF MINNESOTA
15
BMP4 Engineered Mesenchymal Stem Cell Therapy for Glioblastoma 3R01CA183827-03S1 $133,280 $133,280 QUINONES-HINOJOSA, ALFREDO MAYO CLINIC JACKSONVILLE
16
BMP4 Engineered Mesenchymal Stem Cell Therapy for Glioblastoma 7R01CA183827-03 $322,194 $322,194 QUINONES-HINOJOSA, ALFREDO MAYO CLINIC JACKSONVILLE
17
Building on the success of the adoptive immunotherapy of cancer ZIA BC 010763 $1,562,883 $390,721 Restifo, Nicholas CCR (NCI)
18
Cancer Prevention and Treatment by Activation of a Brain-Adipocyte Axis 5R01CA166590-05 $319,550 $159,775 CAO, LEI OHIO STATE UNIVERSITY
19
Cancer-targeted local pulmonary immunotherapy with PD-L1 inhibitory peptide secretory genes for the treatment of lung cancer 1R15CA219919-01 $380,000 $380,000 TAMURA, MASAAKI KANSAS STATE UNIVERSITY
20
Career Development in Pediatric and Medical Oncology 5K12CA076930-17 $701,719 $231,567 BERNSTEIN, IRWIN FRED HUTCHINSON CANCER RESEARCH CENTER
21
Cell Production Core Facility ZIC BC 011569 $933,290 $466,645 Somerville, Robert CCR (NCI)
22
Cellular biofactories for therapeutic protein synthesis in tumor microenvironment 5R21CA193064-04 $240,357 $240,357 BHATNAGAR, PARIJAT SRI INTERNATIONAL
23
Clinical production of viral vectors for cancer gene therapy ZIC BC 010989 $556,461 $556,461 Feldman, Steven CCR (NCI)
24
Clinical Scholars Biomedical Research Training Program 2T32CA009512-29A1 $302,877 $60,575 SPRIGGS, DAVID SLOAN-KETTERING INST CAN RESEARCH
25
Colorectal Cancer: Characterization of a new Cre-LoxP Model 1R03CA216160-01 $60,790 $30,395 KHARE, SHARAD UNIVERSITY OF MISSOURI-COLUMBIA
26
Combination Gene Therapy and Th1-Th2 Therapy ZIA BC 011219 $272,402 $136,201 Fowler, Daniel CCR (NCI)
27
Combination Therapy of OvCA with Oligonucleotides and Photodynamic Therapy 5R01CA194064-03 $283,650 $141,825 MING, XIN WAKE FOREST UNIVERSITY HEALTH SCIENCES
28
Common hTERT Promoter Mutations Represent a Novel Therapeutic Target 5R21CA191663-02 $200,970 $200,970 MILLER, DONALD UNIVERSITY OF LOUISVILLE
29
CRLF2 signaling in B-cell acute lymphoblastic leukemia 5R01CA151898-07 $392,969 $196,485 WEINSTOCK, DAVID DANA-FARBER CANCER INST
30
Design of Oncolytic Adenovirus Conjugated with Novel Polymer for Cancer Treatment 5R01CA177932-05 $309,175 $309,175 KIM, SUNG WAN UNIVERSITY OF UTAH
31
Developing a Novel System for Cancer Therapy: Tumor-Targeted Inhibition of Oncogenic MicroRNAs 5F30CA196020-03 $28,344 $14,172 SVORONOS, ALEXANDER YALE UNIVERSITY
32
Development of fully-human anti-CD30 chimeric antigen receptors ZIA BC 011660 $67,909 $67,909 Kochenderfer, James CCR (NCI)
33
DF/HCC Kidney Cancer SPORE 5P50CA101942-13 $2,300,000 $276,000 MCDERMOTT, DAVID BETH ISRAEL DEACONESS MEDICAL CENTER
34
DICER1 and the Pleuropulmonary Blastoma Family Cancer Syndrome 5R01CA143167-07 $407,577 $407,577 HILL, DANA CHILDREN'S RESEARCH INSTITUTE
35
Direct coregulation of Notch1 by Zmiz1 in T-cell leukemia 5R01CA196604-03 $354,563 $177,282 CHIANG, MARK UNIVERSITY OF MICHIGAN
36
Disrupting tumor/bone malignant interactions with multifunctional cytokine sonodelivery 5R01CA196947-02 $350,644 $350,644 FIGUEIREDO, MARXA PURDUE UNIVERSITY
37
DNA-specific pattern recognition receptor activation following DNA electroporation 5R01CA196796-02 $316,169 $158,085 HELLER, LOREE OLD DOMINION UNIVERSITY
38
Duke SPORE in Brain Cancer 5P50CA190991-04 $2,298,025 $91,921 SAMPSON, JOHN DUKE UNIVERSITY
39
Dusp4 in breast cancer: tumor suppressor biology and therapeutic strategies 5R00CA181491-04 $250,586 $125,293 BALKO, JUSTIN VANDERBILT UNIVERSITY MEDICAL CENTER
40
Efficient Delivery of Plasmid DNA to Achieve Appropriate Transgene Expression 5R01CA186730-03 $353,892 $353,892 HELLER, RICHARD OLD DOMINION UNIVERSITY
41
Elucidating the role of microRNAs in the initiation of multiple myeloma 5R00CA172292-05 $248,999 $74,700 ZHAO, JIANJUN CLEVELAND CLINIC LERNER COM-CWRU
42
Engineering Viruses for Cancer Therapy 1R03CA216179-01 $68,748 $68,748 PENG, CHING-AN UNIVERSITY OF IDAHO
43
Enhancing Immunological Memory Using Aptamertargeted siRNA Delivery to T Cells 3R01CA181598-04S1 $100,813 $50,407 GILBOA, ELI UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
44
Enhancing Immunological Memory Using Aptamertargeted siRNA Delivery to T Cells 5R01CA181598-04 $318,513 $159,257 GILBOA, ELI UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
45
Enhancing miRNA Therapeutics through Combinatorial Targeting and Vehicle Free Delivery 1R01CA205420-01A1 $349,399 $174,700 KASINSKI, ANDREA PURDUE UNIVERSITY
46
ENHANCING T CELL THERAPY OF CANCER 5P01CA094237-15 $1,932,287 $966,144 HESLOP, HELEN BAYLOR COLLEGE OF MEDICINE
47
Enhancing viral oncolysis with vasculostatin gene delivery 5R01CA150153-07 $64,775 $64,775 KAUR, BALVEEN OHIO STATE UNIVERSITY
48
Enhancing viral oncolysis with vasculostatin gene delivery 7R01CA150153-08 $336,268 $336,268 KAUR, BALVEEN UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
49
Exploring the therapeutic potential and pathogenic contribution of MTAP deletion in Glioblastoma 1F30CA206336-01A1 $35,090 $35,090 HANSEN, LANDON DUKE UNIVERSITY
50
Extracellular Vesicles (EVs) and Genes in the Biology and Therapy of Gliomas 2P01CA069246-20 $1,387,951 $610,698 BREAKEFIELD, XANDRA MASSACHUSETTS GENERAL HOSPITAL
Total relevant funding to Gene Therapy for this search: $35,689,813
Showing 1 - 50 of 143 results
Go to top